Sage Therapeutics Inc (NASDAQ: SAGE) is 39.04% higher on its value in year-to-date trading and has touched a low of $4.62 and a high of $22.34 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The SAGE stock was last observed hovering at around $7.32 in the last trading session, with the day’s gains setting it 0.23%.
Currently trading at $7.55, the stock is 4.17% and 11.13% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.12 million and changing 3.14% at the moment leaves the stock -6.18% off its SMA200. SAGE registered -65.46% loss for a year compared to 6-month loss of -10.44%.
The stock witnessed a 3.99% gain in the last 1 month and extending the period to 3 months gives it a 38.03%, and is 5.30% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.12% over the week and 3.24% over the month.
Sage Therapeutics Inc (SAGE) has around 353 employees, a market worth around $464.18M and $41.24M in sales. Profit margin for the company is -971.48%. Distance from 52-week low is 63.42% and -66.20% from its 52-week high. The company has generated returns on investments over the last 12 months (-84.24%).
The EPS is expected to grow by 46.51% this year
The shares outstanding are 61.36M, and float is at 54.10M with Short Float at 8.16%.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 6.42 million shares valued at $69.68 million. The investor’s holdings represent 10.6696 of the SAGE Shares outstanding. As of 2024-06-30, the second largest holder is FMR LLC with 5.82 million shares valued at $63.24 million to account for 9.6193 of the shares outstanding. The other top investors are RTW INVESTMENTS, LP which holds 5.48 million shares representing 9.0531 and valued at over $59.52 million, while BLACKROCK INC. holds 8.673 of the shares totaling 5.22 million with a market value of $56.64 million.
Sage Therapeutics Inc (SAGE) Insider Activity
A total of 0 insider transactions have happened at Sage Therapeutics Inc (SAGE) in the last six months, with sales accounting for 0 and purchases happening 0 times.
Sage Therapeutics Inc (SAGE): Who are the competitors?
One of the company’s main competitors (and peers) include Johnson & Johnson (JNJ) that is trading 3.63% up over the past 12 months.Pfizer Inc. (PFE) lies in the list of competitors of the Sage Therapeutics Inc and is -4.60% lower over the same period from SAGEEli Lilly & Co. (LLY) is 19.23% up on the 1-year trading charts.
